Skip to content
Menu
Ranked #72

NewSelf

NewSelf offers compounded semaglutide+ (with B12/Glycine, from $99.97/mo) and compounded tirzepatide+ (with B6/Glycine, from $144.49/mo).

Desk Score 79/100 (C+) · Verified July 2026

Visit NewSelfAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way.

Is NewSelf legit?

Only what NewSelf publishes and what we could check ourselves — nothing inferred. See the methodology.

FDAWarning letter issued to NewSelf Limited dba NewSelf in February 2026. See the FDA warning-letter database.

Certification
NewSelf publishes a LegitScript certification on its own pages.
Where it ships
49 states, as published on the site.
Last checked
July 2026, against NewSelf's own pages.
Published price
NewSelf publishes a figure for semaglutide and tirzepatide — the qualifiers are in "What does NewSelf cost?" below.
What it sells
Compounded medication only, injectable route only.
Licensing & trust
71/100 on the scored dimension of that name — one of the six in our published methodology.

Proceed with care: an FDA warning letter to this company is on the public record. It is a disclosure rather than a disqualification — the letter is linked above, and it is worth reading before you decide.

What does NewSelf cost?

Each figure exactly as NewSelf publishes it, with the condition attached to it spelled out.

Semaglutide

$100/mo (compounded)

That is a flat month-to-month rate: $100 a month, with no plan term attached to the figure.

Median semaglutide figure across this site: $190 a month, of 164 providers with a published month-to-month price and a check date. NewSelf's $100 a month sits $90 below it.

Tirzepatide

$144/mo (compounded)

That is a flat month-to-month rate: $144 a month, with no plan term attached to the figure.

Median tirzepatide figure across this site: $264 a month, of 163 providers with a published month-to-month price and a check date. NewSelf's $144 a month sits $120 below it.

All figures as published on NewSelf's own site and read in July 2026. Prices change — confirm before you order.

Semaglutide
$100/mo
Tirzepatide
$144/mo
Coverage
49 states
Brand-name
Compounded only
Verification
Prices as published on NewSelf's site — verified july 2026. Each figure's full condition is in “What does NewSelf cost?” below.

Weigh NewSelf against the full ranked field on the best semaglutide providers ranking, or line it up against its closest alternatives. Or go one-on-one: NewSelf vs CoreAge Rx. Because NewSelf dispenses compounded medication, it’s worth understanding whether compounded GLP-1 is legit and safe.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency86/100
State access78/100
Molecule range66/100
Onboarding speed84/100
Support responsiveness84/100
Licensing & trust71/100

What we like

  • Semaglutide+ from $99.97/mo — among the lowest prices in the dataset
  • All dosages at the same price — no price escalation as dose increases
  • LegitScript certified with 503A licensed pharmacies
  • Third-party potency, sterility, and endotoxicity testing
  • 48 states + Puerto Rico coverage

Where points come off

  • Not available in Mississippi and Louisiana
  • Compounded only — no brand-name options
  • Site also promotes AI health optimization and longevity (broader platform)
  • FDA issued NewSelf Limited dba NewSelf a warning letter in February 2026; the letter is public in FDA's warning-letter database

The bottom line — C+

Best for: Lowest-cost compounded GLP-1 with pharmacy quality transparency.

NewSelf ranks #72 of 542 providers scored — see #1, CoreAge Rx here.

FDAWarning letter issued to NewSelf Limited dba NewSelf in February 2026. See the FDA warning-letter database.

Related reviews

Everyone else here (24)

Pricing and verification reflect NewSelf's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on NewSelf's site. Not medical advice; see our disclosure.

← Back to the ranking